A study has verified that circ-LDLRAD3 was up-regulated in plasma of pancreatic cancer patients compared with healthy controls, and the level of plasma circ-LDLRAD3 was strongly related to CA19-9, N classification, venous invasion, and lymphatic invasion (64). The gene discussed is LDLRAD3; the disease is familial pancreatic carcinoma.